Dell Technologies heads into its fiscal second-quarter FY2027 report on Tuesday, September 1 with one of the most unusual earnings setups in large-cap technology....
Tenax Therapeutics, Inc. (NASDAQ:TENX) has become one of August’s more unusual biotechnology special situations. The Tenax Therapeutics Levosimendan program...